Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
March 6, 2018 Off

Basilea first outside Europe launch of its hostpital antibiotic Zevtera

By Dino Mustafić

Grupo Biotoscana has launched Basilea’s hospital antibiotic Zevtera (ceftobiprole) in Argentina, Basilea Pharmaceutica said Tuesday.

March 6, 2018 Off

New Scientific Advisory Board member to help guide Hemogenyx toward the release of successful antibody-based therapies

By Dino Mustafić

Hemogenyx Pharmaceuticals has appointed a pioneer in modern cancer research H. Michael Shepard to its Scientific Advisory Board, praising his work…

Italian Fine Foods & Pharmaceuticals to use OptiBiotix Health’s LPLDL
March 6, 2018 Off

Italian Fine Foods & Pharmaceuticals to use OptiBiotix Health’s LPLDL

By Dino Mustafić

OptiBiotix Health has bagged a deal with Italian Fine Foods & Pharmaceuticals N.T.M. S.p.A in which it allows Fine Foods…

Santhera’s study shows safety profile of idebenone at higher dose than now approved for Raxone in Leber’s hereditary optic neuropathy
March 5, 2018 Off

Santhera’s study shows safety profile of idebenone at higher dose than now approved for Raxone in Leber’s hereditary optic neuropathy

By Dino Mustafić

An investigator-initiated trial at the National Institutes of Health (NIH) in an exploratory Phase I/II clinical trial in primary progressive…

Evgen Pharma remains focused on clinical development of SFX-01, commit to explore therapeutic potential of novel sulforaphane analogues
March 5, 2018 Off

Evgen Pharma remains focused on clinical development of SFX-01, commit to explore therapeutic potential of novel sulforaphane analogues

By Dino Mustafić

The results of an evaluation of Evgen Pharma’s novel sulforaphane analogues suggest that some of the analogues merit further study as…

Artios, Masaryk in in-licensing deal for DNA nucleases targeting drug development
March 5, 2018 Off

Artios, Masaryk in in-licensing deal for DNA nucleases targeting drug development

By Dino Mustafić

Artios Pharma has exercised its option to in-license the first nuclease drug development with Masaryk University in the Czech Republic,…

March 5, 2018 Off

Abzena settles with Stanford University over claims against PacificGMP

By Dino Mustafić

Abzena has settled with Stanford University about the claims against PacificGMP.

BMS welcomes new Board member
March 2, 2018 Off

BMS welcomes new Board member

By Dino Mustafić

Bristol-Myers Squibb’s Board of Directors has elected José Baselga, M.D., Ph.D., to the Board, effective March 1, 2018. Dr. Baselga will…

(EDITED) Vertex kicks off phase 3 trial of triple combination regimen for people with the most common genetic form of Cystic Fibrosis
March 1, 2018 Off

(EDITED) Vertex kicks off phase 3 trial of triple combination regimen for people with the most common genetic form of Cystic Fibrosis

By Dino Mustafić

Edit: The first paragraph used to say: Vertex is conducting the global ECLIPSE Phase 3 clinical trial program to evaluate VX-659…

Novavax plans Phase 2 trial of NanoFlu vaccine in third quarter of 2018
March 1, 2018 Off

Novavax plans Phase 2 trial of NanoFlu vaccine in third quarter of 2018

By Dino Mustafić

NanoFlu vaccine was well tolerated over the three-week trial period, Novavax said Thursday, adding it now expects to begin a…

Posts pagination

Previous 1 … 3,399 3,400 3,401 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine